Pages that link to "Q46877254"
Jump to navigation
Jump to search
The following pages link to Synthetic SRC-kinase domain inhibitors and their structural requirements (Q46877254):
Displaying 5 items.
- Down-regulation of phospho-non-receptor Src tyrosine kinases contributes to growth inhibition of cervical cancer cells (Q33598877) (← links)
- Novel dual Src/Abl inhibitors for hematologic and solid malignancies (Q34121339) (← links)
- Targeting cytoskeleton reorganisation as antimetastatic treatment. (Q37800284) (← links)
- Neutrophil migration: moving from zebrafish models to human autoimmunity. (Q38151856) (← links)
- Pharmacological investigations on possible role of Src kinases in neuroprotective mechanism of ischemic postconditioning in mice (Q50697769) (← links)